Accelerate the Startup of Your Clinical Trials Without Sacrificing Quality
Webinar recorded on June 17, 2021
Time is money, especially when it comes to drug development and delays initiating clinical trials are common.
The introduction of new technologies and decentralized approaches has led to more partners and intermediary companies becoming involved in clinical trials.
This proliferation of companies has introduced new challenges for trial sponsors and research shows timelines are getting longer, particularly when it comes to qualifying new providers of clinical trial services.
This webinar includes:
- An overview of current clinical trial performance, including common pitfalls that impact startup cycle times in clinical research
- Opportunities for improvement using an innovative solution which leverages the results of vendor qualification to reduce cycle times and resources in trial initiation
- How to scale and incorporate the insights gleaned from Operation Warp Speed that accelerated vaccines and treatment for COVID-19
Director and a Professor at the Tufts Center for the Study of Drug Development, Tufts University School of Medicine
Head of Client Services at Diligent Pharma, LLC
The Diligent platform will simplify and streamline your provider selection and qualification processes